As shown in Table 5, after adjusting for age, sex, BMI, serum ALT levels and statin use, the presence of T2DM, irrespective of metformin use, was significantly associated with higher plasma levels of TCDCA, TDCA, GCDCA and GDCA. This evidence concerns the gene GPT and type 2 diabetes mellitus.